Here are relevant reports on : no-code-development-platforms-market
-
Infrastructure as Code (IaC) Market by Tool (Configuration Orchestration, Configuration Management), Service, Type (Declarative & Imperative), Infrastructure Type (Mutable & Immutable), Deployment Mode, Vertical and Region - Global Forecast to 2027
The infrastructure as code market size is projected to reach USD 2.3 billion by 2027, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. Some of the major infrastructure as code market vendors are IBM (US), Microsoft (US), AWS (US), Oracle (US), Hashicorp Terraform (US), Google (US), Alibaba Group (China), Dell (US), Rackspace Technology (US), HPE (US), ServiceNow (US), Broadcom (US), Pulumi (US), Puppet (US), Progress Software (US), NetApp (UK), Northern.tech (US), Canonical (UK), Alpacked (Ukraine), Jenkins (US), Gitlab (US), Github (US), Crossplane (US), and Docker (US).
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Preclinical Models In Drug Discovery & Development Market - 2019 By Types, Application & Geography
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023
The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
- Published: April 2018
- Price: $ 11000
- TOC Available:
-
Marine VFD Market by End User Type (Marine Ships, and Offshore Platforms), Application ( Pump, Propulsion, Fan, Compressor, Crane & Hoist, Winch, HVAC, Steering, Scrubber, Shaft Generator, Power Electronics), & Region - Global Forecast to 2030
The Marine VFD market is projected to reach USD 1.6 billion by 2030, at a CAGR of 5.0% during the forecast period. The Marine VFD market is dominated by a few major players that have a wide regional presence. The major players in the Marine VFD market are Siemens (Germany), ABB (Switzerland), Danfoss (Denmark), General Electric (US), and Rockwell Automation (US). Between 2019 and 2023, Strategies such as product launches, contracts, agreements, partnerships, collaborations, alliances, acquisitions, and expansions are followed by these companies to capture a larger share of the Marine VFD market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030
The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Telecom Cloud Market by Component (Platforms, Solutions, Services), NFV Software (VNFs/CNFs, NFVI), Cloud Service Model (SaaS, PaaS, IaaS), Deployment Model (Public, Private, Hybrid), and Region - Global Forecast to 2030
The telecom cloud market is projected to grow from USD 22,261.8 million in 2025 to USD 56,005.8 million by 2030 at a compound annual growth rate (CAGR) of 20.3% from 2025 to 2030. The major vendors covered in the telecom cloud market are AWS (US), Microsoft (US), Google (US), IBM (US), Broadcom (US), Oracle (US), Intellias (Ukraine), Nokia (Finland), Ericsson (Sweden), and Huawei (China). These players have incorporated various organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions to strengthen their international footprint and capture a greater market share. These organic and inorganic strategies have allowed the market players to expand across geographies by offering telecom cloud solutions.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Clinical Manufacturing Services Market by Finished Dosage Formulations (Tablets, Capsules, Oral Dosages), Type (Analytical Services, Formulation Development, Stability/Storage), End-User (Pharmaceuticals Biopharmaceuticals) - Global Forecast to 2023
In the face of limited resources, the pharmaceutical companies have been recently focusing on the areas of their core competency in drug research and development. The capital-intensive nature of pharmaceutical drug R&D activities have created a need to outsource clinical stage manufacturing of drugs. Clinical manufacturing services include development of formulations for clinical trials, analysis of those formulations and their solubility and stability testing services.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
